Galiprant
20 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
20
Total Reports
5
Deaths Reported
2500.0%
Death Rate
Active Ingredients
Galiprant
Administration Routes
OralUnknownIntraperitoneal
Species Affected
Dog 20
Most Affected Breeds
Retriever - Labrador 5
Retriever - Golden 2
Saint Bernard Dog 2
Rottweiler 2
Spitz - German Pomeranian 1
Bulldog - French 1
Shepherd (unspecified) 1
Terrier - Bull - American Pit 1
Boxer (German Boxer) 1
Hound (unspecified) 1
Most Reported Reactions
Vomiting 5
Lethargy (see also Central nervous system depression in Neurological) 5
Inappropriate urination 4
Disorientation 4
Diarrhoea 3
Not eating 3
Limb weakness 3
Wobbliness 3
Lack of efficacy - NOS 3
Musculoskeletal disorder NOS 3
Death by euthanasia 3
Excessive thirst 3
Outcome Breakdown
Outcome Unknown
7 (35.0%)
Ongoing
7 (35.0%)
Euthanized
3 (15.0%)
Died
2 (10.0%)
Recovered/Normal
1 (5.0%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.